<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03299855</url>
  </required_header>
  <id_info>
    <org_study_id>2017-A01079-44</org_study_id>
    <nct_id>NCT03299855</nct_id>
  </id_info>
  <brief_title>MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric?</brief_title>
  <acronym>MOCA-2</acronym>
  <official_title>MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Francois Baclesse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>UCOG (Unite de coordination en Onco-Gériatrie)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Francois Baclesse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study concerns elderly patients with cancer with onco-geriatric assessment.

      This study propose to associate the collection of the results with the Mini-Cog and the CODEX
      with the passing of the MoCA and the MMS tests, as well as a neuropsychological assessment,
      in order to determine if the patients have cognitive impairments, to evaluate the sensitivity
      of these 4 screening tests in elderly patients seeking treatment for their cancer. The
      results of this study will make it possible, where appropriate, to adapt the practice in the
      context of oncogeriatric assessment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 13, 2017</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Passation of MMS and MoCA tests associated to passation of neuropsychological test</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the sensitivity of MoCA test</measure>
    <time_frame>Up 2 months after inclusion, before initiation of treatment</time_frame>
    <description>MoCA is considered clinically relevant if its sensitivity to identify patients with cognitive impairment is at least 75%</description>
  </primary_outcome>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Neoplasms</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Passation of neuropsychological test</intervention_name>
    <description>Passation of MoCA and MMS tests associated with neuropsychological test</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient aged over 70 years

          -  Patient with cancer (solid tumor or haemopathy) for whom a first line treatment is
             envisaged (whatever it is). Surgery and radiotherapy are allowed before entry into the
             study.

          -  Patient candidate for oncogeriatric assessment

          -  Patient agree to participate in the study

          -  Using the French language

        Exclusion Criteria:

          -  Primary central nervous system or cerebral metastasis

          -  Evolutionary psychiatric pathology known (e.g. schizophrenia)

          -  Severe Visual and / or Auditory Impairment

          -  Patients unable to respond to cognitive tests

          -  Patient (s) deprived of liberty, under guardianship or curatorship

          -  Refusal of participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>florence JOLY, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre François Baclesse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Florence JOLY, PhD</last_name>
    <phone>0231455050</phone>
    <email>f.joly@baclesse.unicancer.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie LANGE</last_name>
    <email>m.lange@baclesse.unicancer.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre François Baclesse</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence JOLY, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bérengère BEAUPLET, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Cherbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laure KALUZINSKI, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Henri Becquerel</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier RIGAL, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier</name>
      <address>
        <city>Saint-Lô</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Isabelle CRINIERE, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2017</study_first_submitted>
  <study_first_submitted_qc>October 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 3, 2017</study_first_posted>
  <last_update_submitted>December 20, 2017</last_update_submitted>
  <last_update_submitted_qc>December 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>oncogeriatric</keyword>
  <keyword>MMS</keyword>
  <keyword>MoCA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

